Plasma exchange therapy for thrombotic microangiopathies

Section of Critical Care, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.
Organogenesis (Impact Factor: 2.8). 01/2011; 7(1):28-31. DOI: 10.4161/org.7.1.14027
Source: PubMed


Thrombotic microangiopathies (TMAs) are syndromes associated with thrombocytopenia and multiple organ failure. Plasma exchange is a proven therapy for primary TMA such as thrombotic thrombocytopenic purpura (TTP). There is growing evidence that plasma exchange therapy might also facilitate resolution of organ dysfunction and improve outcomes for secondary TMAs such as disseminated intravascular coagulation (DIC) and systemic inflammation-induced TTP. In this review, we survey the current available evidence and practice of plasma exchange therapy for TMAs.

Download full-text


Available from: Yong Y Han, Mar 14, 2014
Show more